Vir Biotechnology (VIR) Short Interest Ratio & Short Volume $6.29 +0.32 (+5.36%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$6.32 +0.03 (+0.40%) As of 09:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vir Biotechnology Short Interest DataVir Biotechnology (VIR) has a short interest of 10.11 million shares, representing 11.56% of the float (the number of shares available for trading by the public). This marks a 28.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.9, indicating that it would take 4.9 days of the average trading volume of 1.34 million shares to cover all short positions.Current Short Interest10,110,000 sharesPrevious Short Interest7,880,000 sharesChange Vs. Previous Month+28.30%Dollar Volume Sold Short$65.51 millionShort Interest Ratio4.9 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares137,143,000 sharesFloat Size87,460,000 sharesShort Percent of Float11.56%Today's Trading Volume1,003,760 sharesAverage Trading Volume1,335,394 sharesToday's Volume Vs. Average75% Short Selling Vir Biotechnology? Sign up to receive the latest short interest report for Vir Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVIR Short Interest Over TimeVIR Days to Cover Over TimeVIR Percentage of Float Shorted Over Time Vir Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202510,110,000 shares $65.51 million +28.3%11.6%4.9 $6.48 3/15/20257,880,000 shares $56.34 million +1.4%9.0%3.9 $7.15 2/28/20257,770,000 shares $65.19 million +1.3%8.9%3.8 $8.39 2/15/20257,670,000 shares $74.02 million +0.4%8.7%3.8 $9.65 1/31/20257,640,000 shares $79.46 million -2.8%8.7%3.6 $10.40 1/15/20257,860,000 shares $82.53 million +20.0%9.0%3.7 $10.50 12/31/20246,550,000 shares $48.08 million +7.7%7.5%3.4 $7.34 12/15/20246,080,000 shares $45.30 million -1.3%6.9%4.9 $7.45 11/30/20246,160,000 shares $49.03 million +11.8%7.1%5.2 $7.96 11/15/20245,510,000 shares $44.14 million -3.7%6.3%5.3 $8.01 Get the Latest News and Ratings for VIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 10/31/20245,720,000 shares $42.84 million +3.1%6.4%6.3 $7.49 10/15/20245,550,000 shares $43.01 million -3.1%6.3%7.4 $7.75 9/30/20245,730,000 shares $42.92 million -4.0%6.5%7.2 $7.49 9/15/20245,970,000 shares $48.42 million +1.0%6.8%7.2 $8.11 8/31/20245,910,000 shares $48.82 million +5.0%6.7%6 $8.26 8/15/20245,630,000 shares $48.76 million +13.7%6.4%5.2 $8.66 7/31/20244,950,000 shares $50.29 million +4.2%5.5%4.4 $10.16 7/15/20244,750,000 shares $45.46 million -0.2%5.3%4.1 $9.57 6/30/20244,760,000 shares $42.36 million -30.3%5.3%4.2 $8.90 6/15/20246,830,000 shares $66.59 million +13.5%7.7%6.2 $9.75 5/31/20246,020,000 shares $61.83 million -3.1%6.8%6.1 $10.27 5/15/20246,210,000 shares $62.22 million +5.1%7.0%6.4 $10.02 4/30/20245,910,000 shares $50.00 million +14.8%6.6%5.7 $8.46 4/15/20245,150,000 shares $44.14 million +3.8%5.8%4.8 $8.57 3/31/20244,960,000 shares $50.24 million -8.7%5.6%4.6 $10.13 3/15/20245,430,000 shares $58.43 million +6.9%6.2%5 $10.76 2/29/20245,080,000 shares $57.10 million +0.6%5.8%4.4 $11.24 2/15/20245,050,000 shares $52.07 million -12.5%5.8%4.4 $10.31 1/31/20245,770,000 shares $54.24 million -5.1%6.6%4.9 $9.40 1/15/20246,080,000 shares $63.05 million +2.7%6.9%5.1 $10.37 12/31/20235,920,000 shares $59.56 million -6.0%6.7%4.9 $10.06 12/15/20236,300,000 shares $62.75 million +7.5%7.2%5.1 $9.96 11/30/20235,860,000 shares $55.61 million -4.4%6.7%4.1 $9.49 11/15/20236,130,000 shares $59.34 million No Change7.0%4.3 $9.68 10/31/20236,130,000 shares $48.61 million -4.8%7.0%4.5 $7.93 10/15/20236,440,000 shares $53.90 million +0.2%7.4%4.9 $8.37 9/30/20236,430,000 shares $60.25 million +26.6%7.4%4.1 $9.37 9/15/20235,080,000 shares $49.89 million +11.2%5.8%3.3 $9.82 8/31/20234,570,000 shares $57.86 million -9.2%5.4%3.4 $12.66 8/15/20235,030,000 shares $66.09 million +42.1%5.9%4.1 $13.14Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment… 7/31/20233,540,000 shares $49.84 million -10.8%4.2%3 $14.08 7/15/20233,970,000 shares $91.67 million -4.3%4.7%3.5 $23.09 6/30/20234,150,000 shares $101.80 million -0.2%4.9%5 $24.53 6/15/20234,160,000 shares $108.08 million -25.5%4.9%5 $25.98 5/31/20235,580,000 shares $148.82 million +10.5%6.6%6.3 $26.67 5/15/20235,050,000 shares $129.48 million +7.5%6.0%5.1 $25.64 4/30/20234,700,000 shares $118.21 million -1.9%5.6%4.6 $25.15 4/15/20234,790,000 shares $117.59 million +11.9%5.7%4.6 $24.55 3/31/20234,280,000 shares $99.60 million -11.2%5.2%4.2 $23.27 3/15/20234,820,000 shares $113.37 million -1.0%5.8%4.8 $23.52 2/28/20234,870,000 shares $111.04 million +10.7%5.9%5.2 $22.80 2/15/20234,400,000 shares $117.57 million +8.9%5.3%5 $26.72 1/31/20234,040,000 shares $119.38 million +8.3%4.9%4.8 $29.55 1/15/20233,730,000 shares $99.11 million -10.1%4.6%4.5 $26.57 12/30/20224,150,000 shares $105.04 million +9.2%5.1%5.1 $25.31 12/15/20223,800,000 shares $95.72 million -5.5%4.7%4.3 $25.19 11/30/20224,020,000 shares $113.44 million -4.5%5.0%4.2 $28.22 11/15/20224,210,000 shares $115.14 million -4.3%5.3%4.2 $27.35 10/31/20224,400,000 shares $96.71 million +4.3%5.6%4 $21.98 10/15/20224,220,000 shares $87.23 million -14.9%5.4%4 $20.67 9/30/20224,960,000 shares $95.63 million +8.3%6.3%4.8 $19.28 9/15/20224,580,000 shares $93.02 million -6.5%5.9%4.2 $20.31 8/31/20224,900,000 shares $116.38 million -14.0%6.3%4.7 $23.75 8/15/20225,700,000 shares $159.03 million -20.6%7.6%5.7 $27.90 7/31/20227,180,000 shares $199.68 million +1.4%9.8%7.4 $27.81 7/15/20227,080,000 shares $205.46 million -6.0%9.7%7.1 $29.02 6/30/20227,530,000 shares $191.79 million +0.9%10.3%7.1 $25.47 6/15/20227,460,000 shares $178.44 million -4.9%10.2%4.6 $23.92 5/31/20227,840,000 shares $202.35 million -5.2%10.8%4.9 $25.81 5/15/20228,270,000 shares $187.15 million -6.7%11.4%5 $22.63 4/30/20228,860,000 shares $180.30 million +4.2%12.3%5.3 $20.35 4/15/20228,500,000 shares $203.41 million +134.8%11.8%5.1 $23.93 3/31/20223,620,000 shares $93.11 million -3.7%5.1%2 $25.72 3/15/20223,760,000 shares $86.44 million +7.4%5.2%2.8 $22.99 2/28/20223,500,000 shares $88.17 million +2.6%4.9%2.3 $25.19 2/15/20223,410,000 shares $109.94 million +16.4%4.8%2 $32.24 1/31/20222,930,000 shares $100.59 million -17.0%4.1%1.7 $34.33 1/15/20223,530,000 shares $136.61 million -9.3%4.9%2 $38.70 12/31/20213,890,000 shares $162.87 million -23.1%5.4%2.6 $41.87 12/15/20215,060,000 shares $261.20 million -8.3%7.0%3.3 $51.62 11/30/20215,520,000 shares $261.76 million +3.6%7.9%4.5 $47.42 11/15/20215,330,000 shares $175.30 million -0.7%7.7%5.8 $32.89 10/29/20215,370,000 shares $202.61 million -1.1%7.8%5.6 $37.73 10/15/20215,430,000 shares $212.26 million +3.4%7.9%5.6 $39.09 9/30/20215,250,000 shares $228.48 million -8.1%7.7%5.4 $43.52 9/15/20215,710,000 shares $298.69 million -2.9%8.3%6.2 $52.31 8/31/20215,880,000 shares $303.06 million -13.2%8.6%6.7 $51.54 8/13/20216,770,000 shares $286.98 million -14.6%9.9%7.5 $42.39 7/30/20217,930,000 shares $282.70 million -7.9%11.6%10.1 $35.65 7/15/20218,610,000 shares $312.28 million +2.3%12.4%12.1 $36.27Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment… 6/30/20218,420,000 shares $398.10 million -6.6%12.3%11.6 $47.28 6/15/20219,010,000 shares $394.10 million +4.7%14.2%12.7 $43.74 5/28/20218,610,000 shares $360.85 million +0.8%13.6%9.6 $41.91 5/14/20218,540,000 shares $337.76 million +1.8%13.6%8.1 $39.55 4/30/20218,390,000 shares $401.29 million +1.9%14.0%7.2 $47.83 4/15/20218,230,000 shares $374.88 million +4.1%13.9%4.8 $45.55 3/31/20217,910,000 shares $377.86 million -5.4%13.6%4.2 $47.77 3/15/20218,360,000 shares $441.58 million +3.1%14.9%4.3 $52.82 2/26/20218,110,000 shares $519.93 million -3.9%14.5%4.7 $64.11 2/12/20218,440,000 shares $607.43 million -14.3%15.1%5.6 $71.97 1/29/20219,850,000 shares $578.49 million -31.9%17.5%6.4 $58.73 1/15/202114,470,000 shares $528.01 million +8.2%30.5%10.6 $36.49 12/31/202013,370,000 shares $376.63 million +21.3%28.2%14.1 $28.17 12/15/202011,020,000 shares $359.47 million -4.8%23.2%11.8 $32.62 11/30/202011,570,000 shares $342.93 million +7.5%24.4%10.8 $29.64 10/30/20208,960,000 shares $303.12 million +18.7%19.0%7.6 $33.83 10/15/20207,550,000 shares $310.23 million +4.3%16.0%6.7 $41.09 VIR Short Interest - Frequently Asked Questions What is Vir Biotechnology's current short interest? Short interest is the volume of Vir Biotechnology shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 10,110,000 shares of VIR short. 11.56% of Vir Biotechnology's shares are currently sold short. Learn More on Vir Biotechnology's current short interest. What is a good short interest ratio for Vir Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIR shares currently have a short interest ratio of 5.0. Learn More on Vir Biotechnology's short interest ratio. Which institutional investors are shorting Vir Biotechnology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vir Biotechnology: Jefferies Financial Group Inc., Wolverine Trading LLC, Jefferies Financial Group Inc., Group One Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., JPMorgan Chase & Co., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vir Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.56% of Vir Biotechnology's floating shares are currently sold short. Is Vir Biotechnology's short interest increasing or decreasing? Vir Biotechnology saw a increase in short interest in March. As of March 31st, there was short interest totaling 10,110,000 shares, an increase of 28.3% from the previous total of 7,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vir Biotechnology's float size? Vir Biotechnology currently has issued a total of 137,143,000 shares. Some of Vir Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vir Biotechnology currently has a public float of 87,460,000 shares. How does Vir Biotechnology's short interest compare to its competitors? 11.56% of Vir Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vir Biotechnology: Akero Therapeutics, Inc. (8.54%), Merus (11.36%), Scholar Rock Holding Co. (21.52%), Protagonist Therapeutics, Inc. (8.35%), Crinetics Pharmaceuticals, Inc. (9.80%), SpringWorks Therapeutics, Inc. (12.05%), Organon & Co. (5.89%), Catalyst Pharmaceuticals, Inc. (7.47%), Viking Therapeutics, Inc. (24.12%), Xenon Pharmaceuticals Inc. (5.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Vir Biotechnology stock? Short selling VIR is an investing strategy that aims to generate trading profit from Vir Biotechnology as its price is falling. VIR shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vir Biotechnology? A short squeeze for Vir Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIR, which in turn drives the price of the stock up even further. How often is Vir Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIR, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies AKRO Short Squeeze MRUS Short Squeeze SRRK Short Squeeze PTGX Short Squeeze CRNX Short Squeeze SWTX Short Squeeze OGN Short Squeeze CPRX Short Squeeze VKTX Short Squeeze XENE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIR) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
